An ultra-low dose of nanobodies reduced the number of SARS-CoV-2 virus particles in the hamsters’ nasal cavities, throats and lungs by a millionfold.
Pittsburghers telling the stories of Pittsburgh.
An ultra-low dose of nanobodies reduced the number of SARS-CoV-2 virus particles in the hamsters’ nasal cavities, throats and lungs by a millionfold.
